Filing Details

Accession Number:
0001104659-19-002313
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-17 16:49:59
Reporting Period:
2019-01-15
Accepted Time:
2019-01-17 16:49:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1609550 Inspire Medical Systems Inc. INSP Surgical & Medical Instruments & Apparatus (3841) 261377674
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1737136 P. Timothy Herbert C/O Inspire Medical Systems, Inc.
9700 63Rd Avenue North, Suite 200
Maple Grove MN 55369
Ceo And President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-01-15 3,800 $48.21 255,824 No 4 S Indirect By family trust
Common Stock Disposition 2019-01-15 11,200 $48.86 244,624 No 4 S Indirect By family trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By family trust
No 4 S Indirect By family trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 350 Indirect By daughter
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.58 to $48.57. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.58 to $49.38. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.